Condition
Fibrinolysis Shutdown clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Fibrinolysis Shutdown clinical trials that are recruiting, at sites in 2 countries (most in Australia (1), Russia (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Using fibrinolysis inhibitors after heart surgery to reduce blood transfusions
This study is testing if using a medication to prevent blood clots during and after heart surgery can help reduce the need for blood transfusions in patients.
-
Using viscoelastic testing to guide tPA treatment for acute respiratory failure
This study is testing if using a special blood test can help doctors decide when to give a treatment for blood clots to patients with acute respiratory failure, including those with COVID-19.
Related topics
Quick answers
How many Fibrinolysis Shutdown clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Australia (1 trial), Russia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.